精优药业(00858)发盈警 预期中期亏损约4.5亿港元至4.8亿港元之间 同比盈转亏
EXTRAWELL PHAREXTRAWELL PHAR(HK:00858) 智通财经网·2025-11-20 08:44

Core Viewpoint - The company, 精优药业 (00858), anticipates a loss of approximately HKD 450 million to HKD 480 million for the six months ending September 30, 2025, contrasting with a profit for the same period in 2024 [1] Financial Performance - The expected loss is primarily attributed to unrealized losses on the fair value of the company's convertible bond investments, whereas the corresponding period in 2024 recorded gains from fair value changes [1] - The unrealized loss is classified as non-cash in nature [1] Operational Stability - The company's operational performance remains stable during the current period [1]